{
  "study_identification": {
    "study_id": "Bedford2025",
    "reference_file_names": "Bedford2025.pdf.md; 1-s2.0-S0006322324015130-mmc1.xlsx.md; 1-s2.0-S0006322324015130-mmc2.pdf.md",
    "author_journal_year": "Bedford et al., Biological Psychiatry, 2025",
    "title": "Brain-Charting Autism and Attention-Deficit/Hyperactivity Disorder Reveals Distinct and Overlapping Neurobiology",
    "doi": "10.1016/j.biopsych.2024.07.024"
  },
  "assessment_items_group_a": {
    "clarity_of_research_objectives": {
      "answer": "Yes",
      "confidence_rating": "High",
      "negative_answer_category": "Not Negative",
      "reason": "The research objectives are clearly stated in multiple locations. The abstract states the study used population modeling to characterize cortical anatomy associated with autism and ADHD, benchmarked against models of average brain development. The introduction explicitly states: 'Here, we leveraged models of average brain development previously characterized by our group to quantify alterations related to autism and ADHD. To our knowledge, this is the first study to use population modeling to investigate gray matter alterations related to these conditions in comparison to a common reference sample. We examined sources of variability related to sex, age, and measures of autistic and ADHD traits. Finally, we examined whether a subset of individuals with cooccurring autism and ADHD presented with distinct alterations.' The PICO elements are clearly identifiable: Population (autism and ADHD), Intervention/Exposure (normative modeling application), Comparator (typically developing controls), and Outcome (individual-level deviation patterns in brain anatomy).",
      "supporting_text": "Here, we leveraged models of average brain development previously characterized by our group (98) to quantify alterations related to autism and ADHD. To our knowledge, this is the first study to use population modeling to investigate gray matter alterations related to these conditions in comparison to a common reference sample. We examined sources of variability related to sex, age, and measures of autistic and ADHD traits. Finally, we examined whether a subset of individuals with cooccurring autism and ADHD presented with distinct alterations.",
      "location": "Bedford2025.pdf.md, lines 35-35"
    },
    "clear_definition_of_target_population": {
      "answer": "Yes",
      "confidence_rating": "High",
      "negative_answer_category": "Not Negative",
      "reason": "The target populations are clearly defined. The Methods section specifies: 'Individuals with magnetic resonance imaging data and a primary diagnosis of autism or ADHD or no diagnosis were included.' The final dataset after quality control included 4255 individuals (1869 typically developing control participants [687 female, 1182 male], 987 individuals with ADHD [270 female, 717 male], and 1399 autistic individuals [288 female, 1111 male], ages 2-64 years [mean 14.0, median 12.4]). Demographic characteristics including age and sex are clearly described. The supplementary materials provide detailed diagnostic criteria and demographic information for each dataset.",
      "supporting_text": "The final dataset after quality control (QC) included 4255 individuals (1869 typically developing control participants [687 female, 1182 male], 987 individuals with ADHD [270 female, 717 male], and 1399 autistic individuals [288 female, 1111 male], ages 2-64 years [mean 14.0, median 12.4]) (Figure 1). For details of each dataset, demographics before and after QC, and group differences, see Supplemental Methods Section 1.",
      "location": "Bedford2025.pdf.md, lines 42-43"
    },
    "clarity_of_inclusion_and_exclusion_criteria": {
      "answer": "Yes",
      "confidence_rating": "High",
      "negative_answer_category": "Not Negative",
      "reason": "Inclusion and exclusion criteria are clearly described. The Methods section states: 'Individuals with magnetic resonance imaging data and a primary diagnosis of autism or ADHD or no diagnosis were included.' Quality control procedures are detailed: 'All scans underwent manual QC of raw image and FreeSurfer surface reconstructions using our FSQC tool (107), which allows for the evaluation of both surface reconstruction and raw scan quality, including motion artifacts (108). A cutoff of 2.5 was used for FSQC (107).' Subject numbers at each stage are clearly described with attrition rates provided in the supplementary materials. The supplementary Table S1.2.2 shows participant demographics before and after QC with attrition percentages for each site. The final sample size of 4255 from an initial 4736 indicates clear application of QC criteria.",
      "supporting_text": "Quality Control. All scans underwent manual QC of raw image and FreeSurfer surface reconstructions using our FSQC tool (107), which allows for the evaluation of both surface reconstruction and raw scan quality, including motion artifacts (108). A cutoff of 2.5 was used for FSQC (107). Because even small variations in quality can bias downstream analyses (108,109), we also included the FreeSurfer-derived Euler number (110) as a covariate in all analyses.",
      "location": "Bedford2025.pdf.md, lines 51-51"
    },
    "validity_of_normative_modeling_outcome_measures": {
      "answer": "Yes",
      "confidence_rating": "High",
      "negative_answer_category": "Not Negative",
      "reason": "The outcome measures are clearly defined, valid, and reliable. The study uses centile scores derived from GAMLSS (Generalized Additive Models of Location Scale and Shape) for multiple brain measures including 'total GMV, subcortical GMV (sGMV), white matter volume (WMV), ventricular volume, total SA, mean CT, regional CT, regional cortical volume (CV), and regional SA, while accounting for effects of age, sex, and site/scanner.' The normative reference population is well-characterized: 'Our previous work (98) generated reference models using generalized additive models of location scale and shape to map neuroanatomical developmental trajectories across the life span, using a sample of 75,241 TD individuals.' The interpretation method is clear: 'Centile scores quantify variation in brain development and range from 0 to 1, with 0.5 representing the average of the reference sample.' Methods for quantifying individual-level deviations are detailed in Supplemental Methods Section 2.",
      "supporting_text": "Our previous work (98) generated reference models using generalized additive models of location scale and shape to map neuroanatomical developmental trajectories across the life span, using a sample of 75,241 TD individuals, for total GMV, subcortical GMV (sGMV), white matter volume (WMV), ventricular volume, total SA, mean CT, regional CT, regional cortical volume (CV), and regional SA, while accounting for effects of age, sex, and site/scanner. Models for subcortical structures and the cerebellum were not available at the time of analysis. Out-of-sample centile scores for our study sample were generated based on these reference models using Brent's maximum likelihood estimation [Supplemental Methods Section 2 (98)]. Centile scores quantify variation in brain development and range from 0 to 1, with 0.5 representing the average of the reference sample.",
      "location": "Bedford2025.pdf.md, lines 55-61"
    },
    "handling_of_confounding_variables": {
      "answer": "Yes",
      "confidence_rating": "High",
      "negative_answer_category": "Not Negative",
      "reason": "Key confounding variables are systematically measured and adjusted. The study addresses: 1) Age and sex: 'generalized additive models of location scale and shape to map neuroanatomical developmental trajectories across the life span, using a sample of 75,241 TD individuals... while accounting for effects of age, sex, and site/scanner.' 2) Site effects: 'we first harmonized our data using ComBat (111), consistent with previous work (112). ComBat was applied to the entire dataset across all global and regional measures, with each site treated as a batch and with covariates of age, sex, and diagnosis to preserve related biological variation.' 3) Image quality: 'Because even small variations in quality can bias downstream analyses (108,109), we also included the FreeSurfer-derived Euler number (110) as a covariate in all analyses.' 4) Additional covariates in statistical analyses: 'All analyses included Euler number as a covariate, as well as age, to account for potential systematic age deviations in clinical groups.'",
      "supporting_text": "Generalized additive models of location scale and shape has been shown to adequately account for batch effects related to differences between siteand scanner-specific variables (98). However, we previously (98) noted the relatively lower stability of the out-of-sample models for n < 100. Due to the smaller sample sizes of some sites in our dataset and higher variability in the clinical samples, we first harmonized our data using ComBat (111), consistent with previous work (112). ComBat was applied to the entire dataset across all global and regional measures, with each site treated as a batch and with covariates of age, sex, and diagnosis to preserve related biological variation. ComBat-harmonized data were used as inputs to the out-of-sample maximum likelihood estimation to generate centile scores. We also conducted sensitivity analyses on non-ComBat-harmonized centiles and compared in-sample and out-of-sample centiles (Supplemental Methods Sections 2 and 3).",
      "location": "Bedford2025.pdf.md, lines 63-63"
    },
    "clarity_of_data_sources": {
      "answer": "Yes",
      "confidence_rating": "High",
      "negative_answer_category": "Not Negative",
      "reason": "Data sources are clearly and comprehensively described. The Methods section specifies: 'T1-weighted scans were combined from 49 sites across 7 datasets, including the ABIDE (Autism Brain Imaging Data Exchange) (102,103), the POND (Province of Ontario Neurodevelopmental) Network, the HBN (Healthy Brain Network) at the Child Mind Institute (104), the ADHD200 Consortium, the Multimodal Developmental Neurogenetics of Females with ASD dataset from the National Institute of Mental Health Data Archive, the UK MRC-AIMS (Medical Research Council Autism Imaging Multi-centre Study), and the University of California San Diego Biomarkers of Autism study.' Each dataset is named, and detailed information about data acquisition locations and time periods is provided in the Supplementary Methods Section 1. References to publicly available databases are provided with citations.",
      "supporting_text": "T1-weighted scans were combined from 49 sites across 7 datasets, including the ABIDE (Autism Brain Imaging Data Exchange) (102,103), the POND (Province of Ontario Neurodevelopmental) Network, the HBN (Healthy Brain Network) at the Child Mind Institute (104), the ADHD200 Consortium, the Multimodal Developmental Neurogenetics of Females with ASD dataset from the National Institute of Mental Health Data Archive, the UK MRC-AIMS (Medical Research Council Autism Imaging Multi-centre Study), and the University of California San Diego Biomarkers of Autism study. The final dataset after quality control (QC) included 4255 individuals (1869 typically developing control participants [687 female, 1182 male], 987 individuals with ADHD [270 female, 717 male], and 1399 autistic individuals [288 female, 1111 male], ages 2-64 years [mean 14.0, median 12.4]) (Figure 1). For details of each dataset, demographics before and after QC, and group differences, see Supplemental Methods Section 1.",
      "location": "Bedford2025.pdf.md, lines 41-43"
    },
    "description_of_image_acquisition_protocol": {
      "answer": "Partial",
      "confidence_rating": "Medium",
      "negative_answer_category": "Unclear/Incomplete",
      "reason": "While the study indicates that T1-weighted scans were used and states 'For details of each dataset, demographics before and after QC, and group differences, see Supplemental Methods Section 1', the main text provides limited specific imaging parameters. The supplementary materials provide some information about scanners used (e.g., 'Imaging data was collected using Siemens 3T TrioTim scanner with a 32-channel head coil' for HBN sites, 'General Electric Signa HDxt 1.5T scanner' for UCSD), but comprehensive details about TR, TE, flip angle, and resolution for all sites are not fully provided. Given the multisite nature with 49 sites across 7 datasets, complete imaging parameters are referenced but not comprehensively detailed in a single location. The study does acknowledge this variability: 'the data come from multiple sources, with different scanners, protocols, recruitment procedures, and demographic characteristics.'",
      "supporting_text": "T1-weighted scans were combined from 49 sites across 7 datasets... For details of each dataset, demographics before and after QC, and group differences, see Supplemental Methods Section 1... Our results should be interpreted in light of some limitations. First, as is increasingly common, the data come from multiple sources, with different scanners, protocols, recruitment procedures, and demographic characteristics.",
      "location": "Bedford2025.pdf.md, lines 41-43, 193-195"
    }
  },
  "assessment_items_group_b": {
    "details_of_data_preprocessing": {
      "answer": "Yes",
      "confidence_rating": "High",
      "negative_answer_category": "Not Negative",
      "reason": "Data preprocessing procedures are clearly described. The Methods section specifies: 'T1 images from each dataset were processed using FreeSurfer, version 6.0.1 (105). Regional estimates of each cortical measure were extracted based on the Desikan-Killiany atlas (106).' Quality control procedures are detailed: 'All scans underwent manual QC of raw image and FreeSurfer surface reconstructions using our FSQC tool (107), which allows for the evaluation of both surface reconstruction and raw scan quality, including motion artifacts (108). A cutoff of 2.5 was used for FSQC (107).' The study also describes harmonization: 'we first harmonized our data using ComBat (111), consistent with previous work (112). ComBat was applied to the entire dataset across all global and regional measures, with each site treated as a batch and with covariates of age, sex, and diagnosis to preserve related biological variation.' Software versions, specific preprocessing steps, and QC procedures are all clearly specified.",
      "supporting_text": "FreeSurfer and Cortical Parcellations. T1 images from each dataset were processed using FreeSurfer, version 6.0.1 (105). Regional estimates of each cortical measure were extracted based on the Desikan-Killiany atlas (106). For computational efficiency and because BrainChart models for separate hemispheres were not available at the time of analysis, measures were averaged across hemispheres for each parcellation. Quality Control. All scans underwent manual QC of raw image and FreeSurfer surface reconstructions using our FSQC tool (107), which allows for the evaluation of both surface reconstruction and raw scan quality, including motion artifacts (108). A cutoff of 2.5 was used for FSQC (107). Because even small variations in quality can bias downstream analyses (108,109), we also included the FreeSurfer-derived Euler number (110) as a covariate in all analyses.",
      "location": "Bedford2025.pdf.md, lines 49-51"
    },
    "clarity_of_data_partitioning_methods": {
      "answer": "No",
      "confidence_rating": "High",
      "negative_answer_category": "Missing",
      "reason": "The study does not describe data partitioning into training, validation, and test sets in the traditional machine learning sense. This is because the study uses a pre-existing normative model (BrainCharts) that was previously trained on 75,241 TD individuals. The current study generates out-of-sample centile scores for the clinical populations based on these pre-existing models. The Methods state: 'Our previous work (98) generated reference models using generalized additive models of location scale and shape... using a sample of 75,241 TD individuals... Out-of-sample centile scores for our study sample were generated based on these reference models using Brent's maximum likelihood estimation.' While the study does conduct sensitivity analyses comparing in-sample and out-of-sample centiles (Supplemental Methods Sections 2 and 3), there is no explicit description of data partitioning for model training within this study. The entire clinical dataset appears to be used for generating deviation scores rather than being split into training/validation/test sets.",
      "supporting_text": "Our previous work (98) generated reference models using generalized additive models of location scale and shape to map neuroanatomical developmental trajectories across the life span, using a sample of 75,241 TD individuals, for total GMV, subcortical GMV (sGMV), white matter volume (WMV), ventricular volume, total SA, mean CT, regional CT, regional cortical volume (CV), and regional SA, while accounting for effects of age, sex, and site/scanner. Models for subcortical structures and the cerebellum were not available at the time of analysis. Out-of-sample centile scores for our study sample were generated based on these reference models using Brent's maximum likelihood estimation [Supplemental Methods Section 2 (98)].",
      "location": "Bedford2025.pdf.md, lines 55-61"
    },
    "details_of_normative_modeling_approach": {
      "answer": "Yes",
      "confidence_rating": "High",
      "negative_answer_category": "Not Negative",
      "reason": "The statistical approach used for normative modeling is described in detail. The study specifies: 'Our previous work (98) generated reference models using generalized additive models of location scale and shape to map neuroanatomical developmental trajectories across the life span, using a sample of 75,241 TD individuals.' GAMLSS is a well-established statistical modeling framework. The Methods explain: 'generalized additive models of location scale and shape has been shown to adequately account for batch effects related to differences between siteand scanner-specific variables.' The specific brain measures modeled are listed: 'total GMV, subcortical GMV (sGMV), white matter volume (WMV), ventricular volume, total SA, mean CT, regional CT, regional cortical volume (CV), and regional SA, while accounting for effects of age, sex, and site/scanner.' The method for generating predictions is stated: 'Out-of-sample centile scores for our study sample were generated based on these reference models using Brent's maximum likelihood estimation.' Reference to the original BrainCharts paper (98) provides additional methodological details.",
      "supporting_text": "Generation of Centile Scores Using Generalized Additive Models of Location Scale and Shape. Our previous work (98) generated reference models using generalized additive models of location scale and shape to map neuroanatomical developmental trajectories across the life span, using a sample of 75,241 TD individuals, for total GMV, subcortical GMV (sGMV), white matter volume (WMV), ventricular volume, total SA, mean CT, regional CT, regional cortical volume (CV), and regional SA, while accounting for effects of age, sex, and site/scanner. Models for subcortical structures and the cerebellum were not available at the time of analysis. Out-of-sample centile scores for our study sample were generated based on these reference models using Brent's maximum likelihood estimation [Supplemental Methods Section 2 (98)]. Centile scores quantify variation in brain development and range from 0 to 1, with 0.5 representing the average of the reference sample.",
      "location": "Bedford2025.pdf.md, lines 53-61"
    },
    "details_of_training_algorithm": {
      "answer": "Partial",
      "confidence_rating": "Medium",
      "negative_answer_category": "Unclear/Incomplete",
      "reason": "The study references a pre-existing normative model (BrainCharts) that was trained in previous work. While the statistical framework (GAMLSS) is specified, detailed training algorithm specifics such as optimization algorithms, hyperparameter setting methods, convergence criteria, and regularization techniques are not described in the current paper. The Methods state: 'Our previous work (98) generated reference models using generalized additive models of location scale and shape' and 'Out-of-sample centile scores for our study sample were generated based on these reference models using Brent's maximum likelihood estimation [Supplemental Methods Section 2 (98)].' Brent's method is mentioned for out-of-sample estimation, but details about the original model training (gradient descent methods, convergence criteria, number of epochs, etc.) are not provided in this paper. These details would be found in the referenced BrainCharts paper (reference 98), but they are not replicated here. Given that this is a normative modeling application study rather than a methods development study, this level of detail may be acceptable, but it is not fully present in the current manuscript.",
      "supporting_text": "Our previous work (98) generated reference models using generalized additive models of location scale and shape to map neuroanatomical developmental trajectories across the life span, using a sample of 75,241 TD individuals... Out-of-sample centile scores for our study sample were generated based on these reference models using Brent's maximum likelihood estimation [Supplemental Methods Section 2 (98)].",
      "location": "Bedford2025.pdf.md, lines 55-61"
    },
    "model_performance_evaluation_metrics": {
      "answer": "No",
      "confidence_rating": "High",
      "negative_answer_category": "Missing",
      "reason": "The study does not report traditional model performance evaluation metrics such as MSLL, Pearson correlation, Spearman correlation, or RÂ² for the normative models. This is because the study applies pre-existing normative models (BrainCharts) to generate centile scores for clinical populations rather than training and evaluating new models. The statistical analyses focus on group comparisons using the generated centile scores: 'Separate multiple linear regressions were used to examine diagnostic group differences in centile scores for all global volumes and regional measures.' Effect sizes (Cohen's d) and p-values are reported for group differences, but model performance metrics evaluating how well the normative model fits the data or predicts brain measures are not provided. The study does mention sensitivity analyses comparing in-sample and out-of-sample centiles ('We also conducted sensitivity analyses on non-ComBat-harmonized centiles and compared in-sample and out-of-sample centiles') but does not report quantitative performance metrics.",
      "supporting_text": "Group Differences and Sex Modulation Effects. Separate multiple linear regressions were used to examine diagnostic group differences in centile scores for all global volumes and regional measures...All analyses included Euler number as a covariate, as well as age, to account for potential systematic age deviations in clinical groups. Multiple comparisons were controlled for using the false discovery rate correction (116), separately for each analysis and cortical measure. Cohen's d effect sizes were calculated using the 't_to_d' function in the 'effectsize' package in R (117).",
      "location": "Bedford2025.pdf.md, lines 67-69"
    },
    "implementation_of_internal_validation": {
      "answer": "Partial",
      "confidence_rating": "Medium",
      "negative_answer_category": "Unclear/Incomplete",
      "reason": "The study implements some forms of internal validation through sensitivity analyses, but does not conduct traditional internal validation on independent validation sets. The Methods mention: 'We also conducted sensitivity analyses on non-ComBat-harmonized centiles and compared in-sample and out-of-sample centiles (Supplemental Methods Sections 2 and 3).' The study also reports: 'Results using in-sample and non-ComBat harmonized data were highly similar' and conducts multiple sensitivity analyses including 'controlling for global brain measures, using different QC methods, analysis of equal sex-matched subsamples.' Additionally, the study uses cross-validation-like approaches: 'out-of-sample centiles were generated for our dataset, despite some of these being included in the original BrainCharts models, to properly account for site differences.' However, the study does not explicitly describe traditional cross-validation procedures (e.g., K-fold cross-validation) or evaluation on a held-out validation set separate from training data within this study, as the normative models were pre-trained. The validation approaches are more focused on testing robustness to different preprocessing choices and harmonization methods rather than traditional model validation.",
      "supporting_text": "We also conducted sensitivity analyses on non-ComBat-harmonized centiles and compared in-sample and out-of-sample centiles (Supplemental Methods Sections 2 and 3)... Results using in-sample and non-ComBat harmonized data were highly similar... Other sensitivity analyses included controlling for global brain measures, using different QC methods, analysis of equal sex-matched subsamples, and examining differences in the level of multimodality of the distributions between groups, potentially suggesting the existence of subgroups and investigating dimensional associations between cortical measures and autistic and ADHD traits (Supplemental Methods Sections 5-9).",
      "location": "Bedford2025.pdf.md, lines 63, 127, 71-73"
    },
    "external_data_validation": {
      "answer": "No",
      "confidence_rating": "High",
      "negative_answer_category": "Not Applicable",
      "reason": "External validation on independent datasets not used for generating the centile scores is not conducted in this study. The normative models (BrainCharts) used in this study were trained on 75,241 TD individuals in previous work, and the current study applies these models to clinical populations (autism and ADHD). While the clinical populations are technically 'external' to the normative model training sample, this is the primary analysis of the study rather than external validation per se. The study states: 'out-of-sample centiles were generated for our dataset, despite some of these being included in the original BrainCharts models, to properly account for site differences. Sensitivity analyses demonstrate the stability of the models.' However, there is no separate independent external validation dataset analyzed to test the generalizability of the findings. The nature of this study is application of pre-existing normative models to clinical populations rather than model development with external validation. Given the study design, traditional external validation may not be applicable.",
      "supporting_text": "Additionally, out-of-sample centiles were generated for our dataset, despite some of these being included in the original BrainCharts models, to properly account for site differences. Sensitivity analyses demonstrate the stability of the models; however, we caution that doing so in smaller sites could lead to overestimation of effects.",
      "location": "Bedford2025.pdf.md, lines 195"
    },
    "description_of_dataset_characteristics": {
      "answer": "Yes",
      "confidence_rating": "High",
      "negative_answer_category": "Not Negative",
      "reason": "Dataset characteristics are comprehensively described. Sample sizes are clearly specified: 'The final dataset after quality control (QC) included 4255 individuals (1869 typically developing control participants [687 female, 1182 male], 987 individuals with ADHD [270 female, 717 male], and 1399 autistic individuals [288 female, 1111 male], ages 2-64 years [mean 14.0, median 12.4]).' Demographic characteristics including age distribution, sex ratio, and diagnostic group breakdown are provided in the main text and supplementary tables. The supplementary materials include detailed tables (S1.2.1, S1.2.2, S1.2.3, S1.2.4, S1.2.5) showing participant demographics by study and by site, both before and after QC, with attrition rates. Table S1.2.5 shows 'Characteristics of, and significant differences between, diagnostic groups (post QC).' Clinical characteristics are discussed: 'Dimensional analyses of autistic and ADHD traits revealed limited significant but weak associations between some clinical and cortical measures.' Missing data handling is addressed through QC procedures, though the study acknowledges: 'the lack of consistent phenotypic and diagnostic information led to limited data in the analyses of clinical measures and co-occurring diagnoses.'",
      "supporting_text": "The final dataset after quality control (QC) included 4255 individuals (1869 typically developing control participants [687 female, 1182 male], 987 individuals with ADHD [270 female, 717 male], and 1399 autistic individuals [288 female, 1111 male], ages 2-64 years [mean 14.0, median 12.4]) (Figure 1). For details of each dataset, demographics before and after QC, and group differences, see Supplemental Methods Section 1.",
      "location": "Bedford2025.pdf.md, lines 42-43"
    },
    "performance_metrics_and_statistical_uncertainty": {
      "answer": "Yes",
      "confidence_rating": "High",
      "negative_answer_category": "Not Negative",
      "reason": "Performance metrics and measures of statistical uncertainty are clearly reported. The study reports: 1) Point estimates: Cohen's d effect sizes are provided throughout (e.g., 'd = 0.13 to 0.15' for autism STG alterations, 'd = -0.07 to -0.18' for ADHD CV/SA). 2) P-values: Both raw p-values and FDR-corrected q values are reported in tables (e.g., Table 1 shows p values, q values, and Cohen's d for global measures). 3) Statistical significance: 'Multiple comparisons were controlled for using the false discovery rate correction (116), separately for each analysis and cortical measure.' 4) Confidence in estimates: The study reports correlation coefficients with p-values (e.g., 'partial r = 0.11' for autism age-CT correlation, 'rho = 0.34-0.59; p spin = .0005-.029' for ADHD sex effects). Supplementary tables (S11.1-S11.4) provide comprehensive effect sizes and FDR-corrected p-values for all regional analyses. While confidence intervals are not explicitly reported, the combination of effect sizes, p-values, and FDR correction provides clear measures of statistical uncertainty.",
      "supporting_text": "All analyses included Euler number as a covariate, as well as age, to account for potential systematic age deviations in clinical groups. Multiple comparisons were controlled for using the false discovery rate correction (116), separately for each analysis and cortical measure. Cohen's d effect sizes were calculated using the 't_to_d' function in the 'effectsize' package in R (117)... In autistic individuals, CT and CV, but not SA, centiles were increased in the STG (d = 0.13 to 0.15) only. Individuals with ADHD had significantly lower CV and SA centiles across most cortical regions (d = -0.07 to -0.18) but higher CT centiles (d = 0.09 to 0.10).",
      "location": "Bedford2025.pdf.md, lines 69, 91-92"
    },
    "consideration_for_reproducibility": {
      "answer": "Partial",
      "confidence_rating": "Medium",
      "negative_answer_category": "Unclear/Incomplete",
      "reason": "The study provides some information for reproducibility but is incomplete in certain areas. Software versions are specified: 'T1 images from each dataset were processed using FreeSurfer, version 6.0.1 (105)' and 'Cohen's d effect sizes were calculated using the 't_to_d' function in the 'effectsize' package in R (117).' The normative models are available through the referenced BrainCharts work. However, code availability is not explicitly mentioned in the paper. Data availability is discussed with limitations: 'Data from multiple publicly available datasets (ABIDE, HBN, ADHD200, Female ASD, UCSD) are mentioned, but the POND and UK-AIMS datasets may have restricted access. The paper states regarding limitations: 'the lack of consistent phenotypic and diagnostic information led to limited data in the analyses of clinical measures.' There is no explicit statement about code sharing (e.g., 'Code is available at...' or 'Code available upon request'). The Methods reference the FSQC tool and other established tools, but availability of custom analysis scripts is not mentioned. Given these partial descriptions, reproducibility is possible but not fully facilitated.",
      "supporting_text": "FreeSurfer and Cortical Parcellations. T1 images from each dataset were processed using FreeSurfer, version 6.0.1 (105). Regional estimates of each cortical measure were extracted based on the Desikan-Killiany atlas (106)... Cohen's d effect sizes were calculated using the 't_to_d' function in the 'effectsize' package in R (117)... T1-weighted scans were combined from 49 sites across 7 datasets, including the ABIDE (Autism Brain Imaging Data Exchange) (102,103), the POND (Province of Ontario Neurodevelopmental) Network, the HBN (Healthy Brain Network) at the Child Mind Institute (104), the ADHD200 Consortium, the Multimodal Developmental Neurogenetics of Females with ASD dataset from the National Institute of Mental Health Data Archive, the UK MRC-AIMS (Medical Research Council Autism Imaging Multi-centre Study), and the University of California San Diego Biomarkers of Autism study.",
      "location": "Bedford2025.pdf.md, lines 49, 69, 41-42"
    },
    "interpretation_specific_to_normative_modeling": {
      "answer": "Yes",
      "confidence_rating": "High",
      "negative_answer_category": "Not Negative",
      "reason": "The interpretation of individual-level deviation patterns and their clinical significance is thoroughly discussed. The study explains centile scores: 'Centile scores quantify variation in brain development and range from 0 to 1, with 0.5 representing the average of the reference sample.' Clinical implications are discussed: 'Population modeling provides a framework for studying diverse conditions in reference to a common baseline, which allows us to better quantify individual differences and address heterogeneity and multisite datasets. Population modeling also provides a potential route toward clinical and translational applications of neuroimaging (101). Similar to the use of pediatric growth charts, by characterizing typical brain development, we can identify individually specific alterations from these trajectories that may be associated with neurodevelopmental conditions even before associated traits manifest clinically.' The Discussion addresses advantages over traditional approaches: 'Previous population modeling studies on a single diagnostic cohort have mainly observed divergence from typical brain development in individualized patterns... We note that our sample size is considerably larger than that of previous studies, so while we also observed individualized patterns of centile scores, we may have had more power to detect average group differences.' The study also examines individual-level patterns: 'We also examined the amount of regional overlap in participants in each group with the greatest divergences from the average centile score.' Prospects for clinical application are realistically discussed with acknowledgment of limitations.",
      "supporting_text": "Population modeling, often referred to as normative modeling, has proven effective for characterizing age-dependent variation in brain development (98,99) and has recently been employed in studying autism and ADHD (48,54,89,100). Population modeling provides a framework for studying diverse conditions in reference to a common baseline, which allows us to better quantify individual differences and address heterogeneity and multisite datasets. Population modeling also provides a potential route toward clinical and translational applications of neuroimaging (101). Similar to the use of pediatric growth charts, by characterizing typical brain development, we can identify individually specific alterations from these trajectories that may be associated with neurodevelopmental conditions even before associated traits manifest clinically.",
      "location": "Bedford2025.pdf.md, lines 33-33"
    }
  },
  "additional_comments": {
    "additional_comments": "This is a high-quality, large-scale normative modeling study with several strengths: (1) Very large sample size (N=4255 after QC) from multiple sites and datasets, providing robust statistical power; (2) Sex-balanced analysis with explicit examination of sex differences, addressing a major gap in the field; (3) Comprehensive quality control procedures with detailed reporting of attrition; (4) Rigorous statistical approach with FDR correction and multiple sensitivity analyses; (5) Use of established, validated normative models (BrainCharts) based on 75,241 individuals; (6) Innovative examination of co-occurring autism+ADHD phenotype. Limitations acknowledged by authors include: (1) Multisite data with heterogeneous protocols, though harmonization was performed; (2) Small effect sizes with limited clinical significance; (3) Cortical measures averaged across hemispheres, potentially missing asymmetry effects; (4) Lack of consistent phenotypic data limiting trait-based analyses; (5) Sample representativeness issues (male-biased, limited diversity, insufficient representation of low IQ/high support needs); (6) Lack of longitudinal data preventing trajectory analysis. The study represents state-of-the-art application of normative modeling to neurodevelopmental conditions, though some methodological details (imaging parameters, training algorithms, model performance metrics) are incomplete or referenced to previous work. Code and some data availability are not explicitly stated, which may limit reproducibility. Overall, this is a methodologically rigorous study that advances understanding of autism and ADHD neurobiology through normative modeling."
  }
}
